Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 1/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 3/20 | 0.42 |
| ▸ | MAOB | P27338 | 3/20 | 0.42 |
| ▸ | PDE5A | O76074 | 1/20 | 0.40 |
| ▸ | PDE1A | P54750 | 1/20 | 0.40 |
| ▸ | PDE1B | Q01064 | 1/20 | 0.40 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.40 |
| ▸ | IKBKE | Q14164 | 2/20 | 0.38 |
| ▸ | TBK1 | Q9UHD2 | 2/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24860958 | 0.98 | XDH (0.47) | XDHNPY1RNPY2RMAOAMAOB | |
| SCHEMBL15716135 | 0.95 | XDH (0.44) | XDHNPY1RNPY2RMAOAMAOB | |
| SCHEMBL17289661 | 0.85 | TBK1 (0.38) | XDHNPY1RNPY2RMAOAMAOB | |
| SCHEMBL1667546 | 0.85 | TBK1 (0.51) | IKBKETBK1 | |
| SCHEMBL17289929 | 0.83 | TBK1 (0.46) | XDHIKBKETBK1 | |
| SCHEMBL17289632 | 0.82 | TBK1 (0.42) | XDHIKBKETBK1SLC6A4 | |
| SCHEMBL17630708 | 0.82 | TBK1 (0.40) | XDHNPY1RNPY2RMAOAMAOB | |
| SCHEMBL17289631 | 0.82 | NOS3 (0.36) | XDHNPY1RNPY2RMAOAMAOB | |
| SCHEMBL2724566 | 0.82 | KCNJ1 (0.40) | NPY1RNPY2RMAOAMAOBSLC6A4 | |
| SCHEMBL4426792 | 0.81 | XDH (0.46) | XDHMAOAMAOBPDE5APDE1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110078668-B | Phenyl imidazole XOR inhibitor, preparation and application | 华南理工大学 | 2023-03-24 | — | — | CN | disclosed |
| US-20150344473-A1 | TANK-BINDING KINASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2015-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150344473-A1 | TANK-BINDING KINASE INHIBITOR COMPOUNDS | TBKBP1, TNKS1BP1, TNKS | XDH 3680/4885NPY1R 4782/4885NPY2R 4780/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.